^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    EOC237

    i
    Other names: EOC237
    Associations

    News

    Trials
    Company:
    EOC Pharma
    Drug class:
    CDK7 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    A Study of EOC237 in Patients With Advanced Solid Tumor (clinicaltrials.gov)
    P1, N=48, Not yet recruiting, Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., Ltd
    New P1 trial • Metastases
    |
    EOC237